Contrasted effects of the multitarget TKi vandetanib on docetaxel-sensitive and docetaxel-resistant prostate cancer cell lines-Reference-Cited by-同舟云学术

Contrasted effects of the multitarget TKi vandetanib on docetaxel-sensitive and docetaxel-resistant prostate cancer cell lines

Published:2013-11 Issue:8 Volume:31 Page:1567-1575
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Guérin Olivier,Etienne-Grimaldi Marie-Christine,Monteverde Martino,Sudaka Anne,Brunstein Marie-Christine,Formento Patricia,Lattanzio Laura,Maffi Monica,Tonissi Federica,Ortholan Cécile,Pagès Gilles,Fischel Jean-Louis,Lo Nigro Cristiana,Merlano Marco,Milano Gérard

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference27 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. A retrospective study of the time to clinical endpoints for advanced prostate cancer;Sharifi;BJU Int,2005

3. Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer;Di Lorenzo;Clin Cancer Res,2002

4. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

5. Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma;Strohmeyer;Anticancer Res,2004

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. To Investigate Growth Factor Receptor Targets and Generate Cancer Targeting Inhibitors;Current Topics in Medicinal Chemistry;2023-12

2. Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets;International Journal of Molecular Sciences;2021-09-14

3. Targeting the Extra-Cellular Matrix—Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors;Frontiers in Oncology;2020-07-22